Semcon - Sequential recovery still the story after Q2
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Nyhet

Semcon - Sequential recovery still the story after Q2

Exciting growth in Life Science (+39% y-o-y) Small changes to our estimates Fair value range of SEK 115-170 (111-162) Q2: Automotive recovers, Manufacturing still recovering Semcon reported Q2 net sales of SEK 445m (+11% y-o-y, 9% organic), which was roughly in line with ABGSCe at SEK 448m. Management continues to execute on its target to diversify the revenue mix with strong growth for Life Science sales (+39% y-o-y) within EDS and the acquisition of Squeed. We also note that Automotive revenues within EDS were up 2% y-o-y, indicating a trend shift from the six-year strategic shift away from that end market. Our thesis is that there are growth possibilities within Automotive, with autonomy and mobility acting as growth drivers in this space.

On the other hand, the Manufacturing end market within EDS still has some way to go to regain y-o-y growth, with sales down 12% y-o-y in Q2 (still an improvement from Q1, which saw a 26% y-o-y decline). Adj. EBIT was SEK 40.

2m (39. 8m), corresponding to an adj. EBIT margin 9.

0% (9. 9%); we expected 9. 3%.

Some ups and downs to estimates We only make minor adjustments to our estimates following the Q2 report. In total, it results in 0-1% EBIT downgrades for ‘21e-‘23e. The revisions mainly stem from the EDS business area, where we make negative adjustments to our Manufacturing sales assumption.

This is slightly offset by increases in Automotive and Life Science. M&A activity picking up pace, still a healthy cash position We raise our fair value range to SEK 115-170 (111-162) as the valuation of our core peers has increased since our latest update. The fair value range still corresponds to 5-35% below our key peers on ‘22e P/E.

The same exercise on ‘22e EV/EBIT yields a value range of SEK 139-203. With two acquisitions since March 2020, we think Semcon has started to prove itself within M&A, and an EV/EBIT comparison makes more sense today than it did one year ago. M&A capacity is still healthy with a net cash position of.

Artikeln i sin helhet
Denna källa har få eller inga artiklar bakom betalvägg
Läs hela artikeln

Börskollens app – Högt betyg ⭐⭐⭐⭐⭐ och 250.000 nedladdningar

Ladda hem

Vårt nyhetsbrev – Utvalda börsnyheter och heta investeringscase varje vecka

Prenumerera

Läses av andra just nu

Innehåller annonslänkar

Så kommer du igång med trading

Den här månaden har vi valt att lyfta fram trading som utbildningstema, så att du som läsare ska få en möjlighet att fördjupa dig mer och spetsa dina kunskaper. Nedan finner du ett antal matiga guider och vi lyfter även fram vårt förstahandsval av mäklare och plattform: IG.

STÄNG X
Bästa valet för trading – Bra erbjudande & gratis utbildning
Världsledande global tradingmäklare med prisbelönt app
Gratis att öppna konto & demokonto (fiktiv handel)
KOM IGÅNG

74% av alla icke-professionella kunder förlorar pengar på CFD-handel hos de här leverantörerna.

Populära ekonominyheter

Mer från Introduce

Vinnare & Förlorare

Börskollen använder själva TradingView för analys – prova du med (affiliatelänk)Analysera aktier här

Nyhetsbrev

Senaste nytt